Cardinal Health, Inc. $CAH Stock Purchased by Ritholtz Wealth Management

Ritholtz Wealth Management grew its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 13.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 35,614 shares of the company’s stock after acquiring an additional 4,287 shares during the period. Ritholtz Wealth Management’s holdings in Cardinal Health were worth $7,924,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in CAH. Bank of New York Mellon Corp acquired a new stake in Cardinal Health during the 2nd quarter worth approximately $308,640,000. First Nebraska Trust Co bought a new stake in Cardinal Health in the 2nd quarter valued at $20,050,000. Castlekeep Investment Advisors LLC bought a new stake in Cardinal Health in the 2nd quarter valued at $1,177,000. Saudi Central Bank boosted its stake in Cardinal Health by 87.8% in the 2nd quarter. Saudi Central Bank now owns 16,472 shares of the company’s stock valued at $3,913,000 after purchasing an additional 7,702 shares during the period. Finally, Nilsine Partners LLC grew its holdings in Cardinal Health by 437.7% in the 2nd quarter. Nilsine Partners LLC now owns 6,049 shares of the company’s stock valued at $1,437,000 after buying an additional 4,924 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Evercore reiterated an “outperform” rating and set a $270.00 price objective on shares of Cardinal Health in a research report on Wednesday, August 12th. Robert W. Baird boosted their target price on shares of Cardinal Health from $251.00 to $274.00 and gave the company an “outperform” rating in a research report on Wednesday, August 12th. Citigroup boosted their target price on shares of Cardinal Health from $265.00 to $280.00 and gave the company a “buy” rating in a research report on Wednesday, August 12th. TD Cowen upped their price target on shares of Cardinal Health from $280.00 to $304.00 and gave the company a “buy” rating in a research note on Monday. Finally, JPMorgan Chase & Co. raised their price target on shares of Cardinal Health from $260.00 to $286.00 and gave the stock a “neutral” rating in a research report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus price target of $275.62.

Cardinal Health Trading Up 0.3%

NYSE CAH opened at $277.63 on Thursday. Cardinal Health, Inc. has a 1-year low of $180.45 and a 1-year high of $286.29. The company has a 50 day moving average of $242.85 and a 200-day moving average of $224.57. The company has a market cap of $64.17 billion, a price-to-earnings ratio of 35.92, a PEG ratio of 2.12 and a beta of 0.53.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, November 5th. The company reported $3.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.94 by $0.32. The business had revenue of $67.51 billion during the quarter, compared to analysts’ expectations of $66.67 billion. Cardinal Health had a negative return on equity of 102.72% and a net margin of 0.71%. The firm’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period in the previous year, the company posted $2.55 earnings per share. On average, equities research analysts forecast that Cardinal Health, Inc. will post 12.96 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 15th. Shareholders of record on Monday, January 4th will be issued a $0.5158 dividend. The ex-dividend date of this dividend is Monday, January 4th. This represents a $2.06 annualized dividend and a yield of 0.7%. Cardinal Health’s payout ratio is currently 26.65%.

Insider Transactions at Cardinal Health

In related news, insider Jessica L. Mayer sold 29,436 shares of the firm’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $236.19, for a total value of $6,952,488.84. Following the transaction, the insider owned 33,076 shares in the company, valued at approximately $7,812,220.44. This trade represents a 47.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Stephen M. Mason sold 35,000 shares of the firm’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $236.40, for a total value of $8,274,000.00. Following the completion of the transaction, the chief executive officer owned 18,061 shares in the company, valued at $4,269,620.40. The trade was a 65.96% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 210,271 shares of company stock worth $49,626,657. Corporate insiders own 0.12% of the company’s stock.

Key Cardinal Health News

These are some of the CAH news items that stood out recently:

• Positive Sentiment: Cardinal Health approved a quarterly dividend of $0.5158 per share, payable January 15, 2027, to shareholders of record on January 4. The declaration provides continued income for shareholders, though the article does not offer a new outlook on dividend growth. Cardinal Health Board of Directors Approves Quarterly Dividend
• Positive Sentiment: Bank of America Securities maintained a Buy rating on CAH, signaling continued analyst confidence. Bank of America Securities Remains a Buy on Cardinal Health
• Positive Sentiment: Zacks highlighted CAH’s momentum and growth characteristics, while a separate screen included the company among stocks with strong interest coverage and financial resilience. These are supportive assessments, not new company announcements. Zacks Cardinal Health Momentum Stock Article

Cardinal Health Profile

Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.